{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:41:09Z","timestamp":1771872069419,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.brainres.2008.11.097","type":"journal-article","created":{"date-parts":[[2008,12,12]],"date-time":"2008-12-12T04:25:39Z","timestamp":1229055939000},"page":"138-148","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Neuroprotection by rasagiline in thiamine deficient rats"],"prefix":"10.1016","volume":"1256","author":[{"given":"Sarah","family":"Eliash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Dror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasson","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Rehavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2008.11.097_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/(SICI)1097-4547(19991101)58:3<456::AID-JNR12>3.0.CO;2-S","article-title":"Rasagiline, a monamine oxidase-B inhibitor protects NGF-differentiated PC-12 cells against oxygen-glucose deprivation","volume":"58","author":"Abu-Raya","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(01)01548-5","article-title":"Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells","volume":"434","author":"Abu-Raya","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0140525X99002034","article-title":"Episodic memory, amnesia, and the hippocampal-anterior thalamic axis","volume":"22","author":"Aggleton","year":"1999","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.brainres.2008.11.097_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1471-4159.2002.01047.x","article-title":"Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan","volume":"82","author":"Akao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2008.11.097_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3940(02)00332-4","article-title":"An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells","volume":"326","author":"Akao","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2008.11.097_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2003.10.067","article-title":"Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline","volume":"355","author":"Bar Am","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2008.11.097_bib7","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1096\/fj.05-3794fje","article-title":"Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine","volume":"19","author":"Bar-Am","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2008.11.097_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1471-4159.2007.04777.x","article-title":"Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro","volume":"103","author":"Bar Am","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2008.11.097_bib9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.neuint.2004.05.007","article-title":"Tricarboxylic acid cycle enzymes following thiamine deficiency","volume":"45","author":"Bubber","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2008.11.097_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF00965326","article-title":"Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. Alpha-ketoglutarate dehydrogenase","volume":"11","author":"Butterworth","year":"1986","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pbb.2006.03.004","article-title":"Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze test","volume":"83","author":"Carvalho","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.11.097_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0091270005277935","article-title":"Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease","volume":"45","author":"Chen","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib13","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","article-title":"Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease","volume":"9","author":"Chen","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.brainres.2008.11.097_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s007020170012","article-title":"Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats","volume":"108","author":"Eliash","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00702-004-0254-4","article-title":"Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model","volume":"112","author":"Eliash","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.wnf.0000240956.49315.be","article-title":"Monoamine oxidase inhibitors: current and emerging agents for Parkinson's disease","volume":"30","author":"Fernandez","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib17","first-page":"495","article-title":"Pharmacology of rasagiline (N-propargyl-1R-aminoindan)","volume":"80","author":"Finberg","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.brainres.2008.11.097_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0197-0186(01)00120-6","article-title":"Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration","volume":"40","author":"Gibson","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2008.11.097_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF00965667","article-title":"Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal","volume":"9","author":"Gibson","year":"1984","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.1999.tb07819.x","article-title":"Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits","volume":"893","author":"Gibson","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2008.11.097_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/MN:31:1-3:043","article-title":"The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration","volume":"31","author":"Gibson","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2008.11.097_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00972141","article-title":"Activities of thiamine-dependent enzymes in two experimental models of thiamine deficiency encephalopathy","volume":"12","author":"Gigu\u00e8re","year":"1987","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(98)00929-7","article-title":"Neuroprotective effect of rasagiline, a selective monamine oxidase-B inhibitor, against closed head injury in the mouse","volume":"366","author":"Huang","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jnr.10756","article-title":"Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death","volume":"74","author":"Huang","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/B:NERE.0000014835.34495.9c","article-title":"Mitochondrial heterogeneity within and between different cell types","volume":"29","author":"Huang","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.brainres.2008.11.097_bib27","doi-asserted-by":"crossref","unstructured":"Karuppagounder S.S., Xu H., Pechman D., Chen L.H., DeGiorgio L.A., Gibson G.E., 2008. Translocation of amyloid precursor protein C-terminal fragments to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism. Neurochem. Res. Mar 4; [Electronic publication ahead of print].","DOI":"10.1007\/s11064-008-9594-z"},{"key":"10.1016\/j.brainres.2008.11.097_bib28","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1074\/jbc.273.10.5821","article-title":"Glyceraldehyde-3-phosphate dehydrogenase, the putative target of antiapoptotic compounds CGP3466 and (R)-deprenyl","volume":"273","author":"Kragten","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2008.11.097_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0166-4328(94)00162-9","article-title":"Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks that correlate with tissue loss in diencephalons, cortex and white matter","volume":"68","author":"Langlais","year":"1995","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0166-4328(05)80155-X","article-title":"Diencephalic lesions, learning impairments, and intact retrograde memory following acute thiamine deficiency in the rat","volume":"48","author":"Langlais","year":"1992","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02080929","article-title":"Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models","volume":"11","author":"Langlais","year":"1996","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2008.11.097_bib32","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2174\/0929867043364793","article-title":"Pharmacological aspects of (-)-deprenyl","volume":"11","author":"Magyar","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"Suppl 72","key":"10.1016\/j.brainres.2008.11.097_bib33","first-page":"165","article-title":"Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse","author":"Magyar","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1037\/0735-7044.105.3.351","article-title":"Analysis of aversively conditioned learning and memory in rats recovered from pyrithiamine-induced thiamine deficiency","volume":"105","author":"Mair","year":"1991","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2008.11.097_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2004.12.027","article-title":"Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives","volume":"48","author":"Mandel","year":"2005","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.brainres.2008.11.097_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2307\/2528282","article-title":"Ranking procedures for arbitrarily restricted observations","volume":"23","author":"Mantel","year":"1967","journal-title":"Biometrics"},{"key":"10.1016\/j.brainres.2008.11.097_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1471-4159.2001.00448.x","article-title":"Transfection-enforced Bcl-2 overexpression and an anti-parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol","volume":"78","author":"Maruyama","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2008.11.097_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1749-6632.2001.tb03641.x","article-title":"Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022","volume":"939","author":"Maruyama","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2008.11.097_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0892-0362(02)00221-0","article-title":"Neuroprotection by propargylamines in Parkinson's disease. Suppression of apoptosis and induction of prosurvival genes","volume":"24","author":"Maruyama","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.brainres.2008.11.097_bib40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s007020200038","article-title":"The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells","volume":"109","author":"Maruyama","year":"2002","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.brainres.2008.11.097_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.brainres.2008.11.097_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1037\/0735-7044.113.1.42","article-title":"Impaired allocentric spatial working memory and intact retrograde memory after thalamic damage caused by thiamine deficiency in rats","volume":"113","author":"Mumby","year":"1999","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2008.11.097_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1471-4159.1997.68010033.x","article-title":"L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro","volume":"68","author":"Mytilineou","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2008.11.097_bib44","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/archneur.59.12.1937","article-title":"A controlled trial of rasagiline in early Parkinson disease","volume":"59","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2008.11.097_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archneur.61.4.561","article-title":"A controlled, randomised, delayed-start study of rasagiline in early Parkinson disease","volume":"61","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2008.11.097_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2005.02.032","article-title":"Cholinergic parameters and the retrieval of learned and re-learned spatial information: a study using a model of Wernicke\u2013Korsakoff Syndrome","volume":"162","author":"Pires","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-4328(00)00350-8","article-title":"Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent","volume":"119","author":"Pitkin","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0166-4328(03)00208-0","article-title":"Age-related vulnerability to diencephalic amnesia produced by thiamine deficiency: the role of time of insult","volume":"148","author":"Pitkin","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01246964","article-title":"Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration","volume":"43","author":"Reynolds","year":"1978","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0006-8993(84)91221-6","article-title":"Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers","volume":"303","author":"Ricaurte","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/B:MEBR.0000020187.98238.58","article-title":"Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissue: an in vivo kinetic study using rats","volume":"18","author":"Rindi","year":"2003","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2008.11.097_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(96)00593-6","article-title":"Selegiline enhances NGF sythesis and protects central nervous system neurons from excitotoxic and ischemic damage","volume":"315","author":"Semkova","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.490370213","article-title":"Increased CNTF gene expresion in process-bearing astrocytes following injury is augmented by R(-)deprenyl","volume":"37","author":"Seniuk","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/cne.903370307","article-title":"Direct projections from the anterior thalamic nuclei to the retrohippocampal region in the rat","volume":"337","author":"Shibata","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2008.11.097_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0091-3057(97)00603-5","article-title":"Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat","volume":"60","author":"Speiser","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2008.11.097_bib56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-3-7091-6499-0_29","article-title":"Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders","volume":"52","author":"Speiser","year":"1998","journal-title":"J. Neural Transm. [Suppl]"},{"key":"10.1016\/j.brainres.2008.11.097_bib57","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s007020050182","article-title":"Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat","volume":"106","author":"Speiser","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00702-006-0612-5","article-title":"Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat","volume":"114","author":"Speiser","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.expneurol.2007.11.022","article-title":"Rasagiline is neuroprotective in a transgenic model of multiple system atrophy","volume":"210","author":"Stefanova","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2008.11.097_bib60","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1002\/ana.10488","article-title":"Neuroprotection in Parkinson's disease: clinical trials","volume":"3","author":"Stocchi","year":"2003","journal-title":"Ann. Neurol. Suppl."},{"key":"10.1016\/j.brainres.2008.11.097_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.189.2.381","article-title":"Mitochondrial release of caspase-2 and -9 during the apoptotic process","volume":"189","author":"Susin","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainres.2008.11.097_bib62","series-title":"Handbook of Chemical Neuroanatomy, Vol 5, Integrated Systems of the CNS, Pt 1","first-page":"125","article-title":"The limbic region. The septohippocampal system","author":"Swanson","year":"1987"},{"key":"10.1016\/j.brainres.2008.11.097_bib63","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1471-4159.1994.63041572.x","article-title":"Deprenyl reduces PC-12 cell apoptosis by inducing new protein synthesis","volume":"63","author":"Tatton","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2008.11.097_bib64","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00702-002-0827-z","article-title":"Neuroprotection by deprenyl and other propargylamines: glyceraldehydes-3-phosphate dehydrogenase rather than monoamine oxidase B","volume":"110","author":"Tatton","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib65","series-title":"Methods in Biogenic Amine Research","first-page":"141","article-title":"The assay of monamine oxidase activity","author":"Tipton","year":"1983"},{"key":"10.1016\/j.brainres.2008.11.097_bib66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1097-4547(19980415)52:2<240::AID-JNR12>3.0.CO;2-B","article-title":"Increased neuronal cell survival after L-deprenyl treatment in experimental thiamine deficiency","volume":"52","author":"Todd","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2008.11.097_bib67","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archneur.1981.00510060052007","article-title":"Model of Wernicke's encephalopathy","volume":"38","author":"Troncoso","year":"1981","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2008.11.097_bib68","first-page":"197","article-title":"Neurorescuing effects of the GADPH ligand CGP 3466B","volume":"60","author":"Waldmeier","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.brainres.2008.11.097_bib69","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1523\/JNEUROSCI.21-18-07323.2001","article-title":"The conjoint importance of the hippocampus and anterior thalamic nuclei for allocentric spatial learning: evidence from a disconnection study in the rat","volume":"21","author":"Warburton","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2008.11.097_bib70","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.04-1916fje","article-title":"Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members","volume":"18","author":"Weinreb","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2008.11.097_bib71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1196\/annals.1344.030","article-title":"Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway","volume":"1053","author":"Weinreb","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2008.11.097_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00702-005-0299-z","article-title":"N-propargylamine protects SH-SY5Y cells from apoptosis induced by endogenous neurotoxin N-methylsalsolinol through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2","volume":"113","author":"Yi","year":"2006","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2008.11.097_bib73","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1096\/fj.03-0078fje","article-title":"The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing","volume":"17","author":"Yogev-Falach","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2008.11.097_bib74","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1015131516649","article-title":"Molecular basis on neuroprotective activities of rasagiline and the anti-Alzheimer's drug, TV3326, [(N-propargyl-(3R)aminoindan-5-yl)-ethyl methyl carbamate]","volume":"21","author":"Youdim","year":"2002","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2008.11.097_bib75","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib76","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0006-2952(03)00535-5","article-title":"The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activation in the neuroprotective antiapoptotic action of the anti-Parkinson drug, rasagiline","volume":"66","author":"Youdim","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2008.11.097_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition","volume":"79","author":"Youdim","year":"2005","journal-title":"J. Neurosci. Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899308028965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899308028965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T13:10:06Z","timestamp":1549631406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899308028965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":77,"alternative-id":["S0006899308028965"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2008.11.097","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}